《港股》恆指半日升308點創四年高 美團京東造好 雲相關股受捧
市場憧憬美聯儲更大幅度減息,外圍股市造好。港股在科技股帶下上升。恆指高開104點後升幅擴大,曾升316點一度高見26,254點四年高,半日升308點或1.2%,報26,246點;國指升112點或1.2%,報9,354點;恆生科技指數升104點或1.8%,報5,933點。大市半日成交總額1,696.14億元。
阿里(09988.HK)針對線下消費點評推高德掃街榜,股價升2.1%。美團(03690.HK)反彈3.3%,電商競爭對手京東(09618.HK)升4.6%。甲骨文料雲業務收入急增市後股價暴漲27%,雲服務股金山雲(03896.HK)及萬國數據(09698.HK)升9.6%及5.8%,百度(09888.HK)亦升3.8%。工信部向聯通(00762.HK)發衛星移動通信業務經營許可,聯通依法開展手機直連衛星等業務,聯通抽高4.2%,長飛光纖光纜(06869.HK)亦升4.5%。
其他科技股方面,騰訊(00700.HK)升1.8%報638元,快手(01024.HK)及網易(09999.HK)升1.9%,嗶哩嗶哩(09626.HK)升6.6%,小米(01810.HK)跌1.1%。網易雲音樂(09899.HK)、微盟(02013.HK)及騰訊(01698.HK)升3.9%至4.2%,中芯(00981.HK)及聯想集團(00992.HK)各升逾3%。車股比亞迪(01211.HK)升0.5%,長汽(02333.HK)跌3.9%。寧德(03750.HK)鋰礦將復產及內地碳酸鋰期貨下挫,鋰業股贛鋒(01772.HK)及天齊(09696.HK)跌6.6%及8.2%,寧德則升0.4%。
醫藥股復星醫藥(02196.HK)、榮昌生物(09995.HK)及康方生物(09926.HK)跌2.6%至3.4%,綠葉製藥(02186.HK)跌3.9%,三生製藥(01530.HK)跌8.1%。
金融股方面,匯控(00005.HK)及港交所(00388.HK)升1.3%及1.9%,友邦(01299.HK)升1.1%,富衛(01828.HK)跌2.9%。內銀股農行(01288.HK)、建行(00939.HK)及招行(03968.HK)升2.3%至2.6%,內險股太保(02601.HK)及財險(02328.HK)升2.6%及2.4%,國壽(02628.HK)升1.9%。金礦股招金(01818.HK)及山東黃金(01787.HK)回吐3%及3.8%。
其他股份方面,本地地產股新地(00016.HK)升3.6%。光伏相關股福萊特(06865.HK)、新特能源(01799.HK)及協鑫科技(03800.HK)跌3.8%至4.3%。零售股泡泡瑪特(09992.HK)跌5.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.